{"entity":{"type":"insider","cik":"0001574558","url":"/insider/0001574558","json_url":"/insider/0001574558.json","name":"Lis William","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":51,"n_filings":27,"first":"2014-05-21","last":"2026-08-13","span_basis":"filed_date"},"name_variants":[{"name":"Lis William","source":"filing","n_filings":27,"first_seen":"2014-05-21","last_seen":"2026-08-13"}],"transactions":[{"id":9206376,"accession":"0000905148-26-003620","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-26-003620","line_url":"/filing/0000905148-26-003620#line-1","is_derivative":false,"issuer_cik":"0001574558","issuer_name":"Zai Lab Ltd","issuer_ticker":"ZLAB","issuer_name_source":null,"issuer_url":"/issuer/0001574558","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8506.0,"shares_display":"8,506","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":212650.0,"total_display":"212,650.00","total_whole":"212,650","shares_owned_after":41931.0,"shares_owned_after_display":"41,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-12","filed_date":"2026-08-13","scope":"insider"},{"id":5768272,"accession":"0000905148-26-003077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-26-003077","line_url":"/filing/0000905148-26-003077#line-1","is_derivative":false,"issuer_cik":"0001574558","issuer_name":"Zai Lab Ltd","issuer_ticker":"ZLAB","issuer_name_source":null,"issuer_url":"/issuer/0001574558","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7040.0,"shares_display":"7,040","price_per_share":18.09,"price_display":"18.09","price_state":"stated","total_value":127353.6,"total_display":"127,353.60","total_whole":"127,354","shares_owned_after":50437.0,"shares_owned_after_display":"50,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider"},{"id":4261673,"accession":"0000905148-25-002215","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-25-002215","line_url":"/filing/0000905148-25-002215#line-2","is_derivative":false,"issuer_cik":"0001574558","issuer_name":"Zai Lab Ltd","issuer_ticker":"ZLAB","issuer_name_source":null,"issuer_url":"/issuer/0001574558","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13814.0,"shares_display":"13,814","price_per_share":35.67,"price_display":"35.67","price_state":"stated","total_value":492745.38,"total_display":"492,745.38","total_whole":"492,745","shares_owned_after":35106.0,"shares_owned_after_display":"35,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-20","filed_date":"2025-06-23","scope":"insider"},{"id":4226553,"accession":"0000905148-25-000827","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-25-000827","line_url":"/filing/0000905148-25-000827#line-1","is_derivative":false,"issuer_cik":"0001574558","issuer_name":"Zai Lab Ltd","issuer_ticker":"ZLAB","issuer_name_source":null,"issuer_url":"/issuer/0001574558","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":32.98,"price_display":"32.98","price_state":"stated","total_value":494700.0,"total_display":"494,700.00","total_whole":"494,700","shares_owned_after":38089.0,"shares_owned_after_display":"38,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-28","filed_date":"2025-03-04","scope":"insider"},{"id":3150010,"accession":"0000905148-24-001839","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-24-001839","line_url":"/filing/0000905148-24-001839#line-2","is_derivative":false,"issuer_cik":"0001574558","issuer_name":"Zai Lab Ltd","issuer_ticker":"ZLAB","issuer_name_source":null,"issuer_url":"/issuer/0001574558","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10297.0,"shares_display":"10,297","price_per_share":17.3139,"price_display":"17.31","price_state":"stated","total_value":178281.2283,"total_display":"178,281.23","total_whole":"178,281","shares_owned_after":53189.0,"shares_owned_after_display":"53,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-03","scope":"insider"},{"id":3150008,"accession":"0000905148-24-001839","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-24-001839","line_url":"/filing/0000905148-24-001839#line-1","is_derivative":false,"issuer_cik":"0001574558","issuer_name":"Zai Lab Ltd","issuer_ticker":"ZLAB","issuer_name_source":null,"issuer_url":"/issuer/0001574558","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":18.04,"price_display":"18.04","price_state":"stated","total_value":1804.0,"total_display":"1,804.00","total_whole":"1,804","shares_owned_after":53089.0,"shares_owned_after_display":"53,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-03","scope":"insider"},{"id":7838882,"accession":"0001013762-23-003901","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-23-003901","line_url":"/filing/0001013762-23-003901#line-1","is_derivative":false,"issuer_cik":"0001574558","issuer_name":"Jasper Therapeutics, Inc.","issuer_ticker":"JSPR","issuer_name_source":null,"issuer_url":"/issuer/0001574558","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7965.0,"shares_display":"7,965","price_per_share":0.8508,"price_display":"0.85","price_state":"stated","total_value":6776.622,"total_display":"6,776.62","total_whole":"6,777","shares_owned_after":53521.0,"shares_owned_after_display":"53,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-13","filed_date":"2023-10-13","scope":"insider"},{"id":8503007,"accession":"0001213900-23-029888","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-029888","line_url":"/filing/0001213900-23-029888#line-1","is_derivative":false,"issuer_cik":"0001574558","issuer_name":"Jasper Therapeutics, Inc.","issuer_ticker":"JSPR","issuer_name_source":null,"issuer_url":"/issuer/0001574558","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":1.44,"price_display":"1.44","price_state":"stated","total_value":12240.0,"total_display":"12,240.00","total_whole":"12,240","shares_owned_after":61486.0,"shares_owned_after_display":"61,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-13","filed_date":"2023-04-14","scope":"insider"},{"id":8506455,"accession":"0000899243-23-007333","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-007333","line_url":"/filing/0000899243-23-007333#line-1","is_derivative":false,"issuer_cik":"0001574558","issuer_name":"Zai Lab Ltd","issuer_ticker":"ZLAB","issuer_name_source":null,"issuer_url":"/issuer/0001574558","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"American Depositary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5434.0,"shares_display":"5,434","price_per_share":38.31,"price_display":"38.31","price_state":"stated","total_value":208176.54,"total_display":"208,176.54","total_whole":"208,177","shares_owned_after":23330.0,"shares_owned_after_display":"23,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-07","scope":"insider"},{"id":6855223,"accession":"0001213900-22-035570","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-22-035570","line_url":"/filing/0001213900-22-035570#line-2","is_derivative":false,"issuer_cik":"0001574558","issuer_name":"Jasper Therapeutics, Inc.","issuer_ticker":"JSPR","issuer_name_source":null,"issuer_url":"/issuer/0001574558","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24743.0,"shares_display":"24,743","price_per_share":2.0775,"price_display":"2.08","price_state":"stated","total_value":51403.5825,"total_display":"51,403.58","total_whole":"51,404","shares_owned_after":40486.0,"shares_owned_after_display":"40,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-27","filed_date":"2022-06-28","scope":"insider"},{"id":6855218,"accession":"0001213900-22-035570","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-22-035570","line_url":"/filing/0001213900-22-035570#line-1","is_derivative":false,"issuer_cik":"0001574558","issuer_name":"Jasper Therapeutics, Inc.","issuer_ticker":"JSPR","issuer_name_source":null,"issuer_url":"/issuer/0001574558","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24743.0,"shares_display":"24,743","price_per_share":2.022,"price_display":"2.02","price_state":"stated","total_value":50030.346,"total_display":"50,030.35","total_whole":"50,030","shares_owned_after":65229.0,"shares_owned_after_display":"65,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-24","filed_date":"2022-06-28","scope":"insider"},{"id":6656180,"accession":"0001567619-22-001445","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-001445","line_url":"/filing/0001567619-22-001445#line-1","is_derivative":false,"issuer_cik":"0001574558","issuer_name":"Zai Lab Ltd","issuer_ticker":"ZLAB","issuer_name_source":null,"issuer_url":"/issuer/0001574558","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1926.0,"shares_display":"1,926","price_per_share":53.4,"price_display":"53.40","price_state":"stated","total_value":102848.4,"total_display":"102,848.40","total_whole":"102,848","shares_owned_after":34114.0,"shares_owned_after_display":"34,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-20","filed_date":"2022-01-21","scope":"insider"},{"id":6605179,"accession":"0001209191-18-036768","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-036768","line_url":"/filing/0001209191-18-036768#line-1","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5113.0,"shares_display":"5,113","price_per_share":45.21,"price_display":"45.21","price_state":"stated","total_value":231158.73,"total_display":"231,158.73","total_whole":"231,159","shares_owned_after":222035.0,"shares_owned_after_display":"222,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-06","filed_date":"2018-06-08","scope":"insider"},{"id":5281410,"accession":"0001209191-17-042399","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-17-042399","line_url":"/filing/0001209191-17-042399#line-9","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14150.0,"shares_display":"14,150","price_per_share":55.35,"price_display":"55.35","price_state":"stated","total_value":783202.5,"total_display":"783,202.50","total_whole":"783,203","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-28","filed_date":"2017-06-29","scope":"insider"},{"id":5281407,"accession":"0001209191-17-042399","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-17-042399","line_url":"/filing/0001209191-17-042399#line-8","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":129271.0,"shares_display":"129,271","price_per_share":54.92,"price_display":"54.92","price_state":"stated","total_value":7099563.32,"total_display":"7,099,563.32","total_whole":"7,099,563","shares_owned_after":125878.0,"shares_owned_after_display":"125,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-27","filed_date":"2017-06-29","scope":"insider"},{"id":5281403,"accession":"0001209191-17-042399","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-17-042399","line_url":"/filing/0001209191-17-042399#line-7","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":112778.0,"shares_display":"112,778","price_per_share":55.9,"price_display":"55.90","price_state":"stated","total_value":6304290.2,"total_display":"6,304,290.20","total_whole":"6,304,290","shares_owned_after":13100.0,"shares_owned_after_display":"13,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-27","filed_date":"2017-06-29","scope":"insider"},{"id":5281400,"accession":"0001209191-17-042399","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-17-042399","line_url":"/filing/0001209191-17-042399#line-6","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13100.0,"shares_display":"13,100","price_per_share":56.57,"price_display":"56.57","price_state":"stated","total_value":741067.0,"total_display":"741,067.00","total_whole":"741,067","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-27","filed_date":"2017-06-29","scope":"insider"},{"id":9270301,"accession":"0001209191-17-027003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-027003","line_url":"/filing/0001209191-17-027003#line-1","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6750.0,"shares_display":"6,750","price_per_share":36.06,"price_display":"36.06","price_state":"stated","total_value":243405.0,"total_display":"243,405.00","total_whole":"243,405","shares_owned_after":4730.0,"shares_owned_after_display":"4,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-11","filed_date":"2017-04-14","scope":"insider"},{"id":4562744,"accession":"0001209191-17-026573","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-026573","line_url":"/filing/0001209191-17-026573#line-1","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6750.0,"shares_display":"6,750","price_per_share":36.06,"price_display":"36.06","price_state":"stated","total_value":243405.0,"total_display":"243,405.00","total_whole":"243,405","shares_owned_after":4730.0,"shares_owned_after_display":"4,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-11","filed_date":"2017-04-11","scope":"insider"},{"id":3126935,"accession":"0001209191-16-117133","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-117133","line_url":"/filing/0001209191-16-117133#line-1","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5675.0,"shares_display":"5,675","price_per_share":23.86,"price_display":"23.86","price_state":"stated","total_value":135405.5,"total_display":"135,405.50","total_whole":"135,406","shares_owned_after":18333.0,"shares_owned_after_display":"18,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-02","filed_date":"2016-05-03","scope":"insider"},{"id":8785992,"accession":"0001209191-15-061015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-061015","line_url":"/filing/0001209191-15-061015#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":2500000.0,"total_display":"2,500,000.00","total_whole":"2,500,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-15","filed_date":"2015-07-15","scope":"insider"},{"id":8300447,"accession":"0001209191-15-059019","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-059019","line_url":"/filing/0001209191-15-059019#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":45.603,"price_display":"45.60","price_state":"stated","total_value":684045.0,"total_display":"684,045.00","total_whole":"684,045","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-02","filed_date":"2015-07-02","scope":"insider"},{"id":8603112,"accession":"0001209191-15-058197","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-058197","line_url":"/filing/0001209191-15-058197#line-6","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14900.0,"shares_display":"14,900","price_per_share":45.536,"price_display":"45.54","price_state":"stated","total_value":678486.4,"total_display":"678,486.40","total_whole":"678,486","shares_owned_after":100.0,"shares_owned_after_display":"100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-01","filed_date":"2015-07-01","scope":"insider"},{"id":8603109,"accession":"0001209191-15-058197","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-058197","line_url":"/filing/0001209191-15-058197#line-5","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":46.07,"price_display":"46.07","price_state":"stated","total_value":4607.0,"total_display":"4,607.00","total_whole":"4,607","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-01","filed_date":"2015-07-01","scope":"insider"},{"id":8603103,"accession":"0001209191-15-058197","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-058197","line_url":"/filing/0001209191-15-058197#line-3","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9600.0,"shares_display":"9,600","price_per_share":44.73,"price_display":"44.73","price_state":"stated","total_value":429408.0,"total_display":"429,408.00","total_whole":"429,408","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-30","filed_date":"2015-07-01","scope":"insider"},{"id":8603099,"accession":"0001209191-15-058197","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-058197","line_url":"/filing/0001209191-15-058197#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5400.0,"shares_display":"5,400","price_per_share":44.026,"price_display":"44.03","price_state":"stated","total_value":237740.4,"total_display":"237,740.40","total_whole":"237,740","shares_owned_after":9600.0,"shares_owned_after_display":"9,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-30","filed_date":"2015-07-01","scope":"insider"},{"id":8249155,"accession":"0001209191-15-037710","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-037710","line_url":"/filing/0001209191-15-037710#line-3","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44900.0,"shares_display":"44,900","price_per_share":35.6,"price_display":"35.60","price_state":"stated","total_value":1598440.0,"total_display":"1,598,440.00","total_whole":"1,598,440","shares_owned_after":100.0,"shares_owned_after_display":"100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-30","filed_date":"2015-05-01","scope":"insider"},{"id":8249151,"accession":"0001209191-15-037710","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-037710","line_url":"/filing/0001209191-15-037710#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":36.18,"price_display":"36.18","price_state":"stated","total_value":3618.0,"total_display":"3,618.00","total_whole":"3,618","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-30","filed_date":"2015-05-01","scope":"insider"},{"id":8864280,"accession":"0001209191-15-005167","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-005167","line_url":"/filing/0001209191-15-005167#line-3","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19800.0,"shares_display":"19,800","price_per_share":27.317,"price_display":"27.32","price_state":"stated","total_value":540876.6,"total_display":"540,876.60","total_whole":"540,877","shares_owned_after":200.0,"shares_owned_after_display":"200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-20","filed_date":"2015-01-20","scope":"insider"},{"id":8864277,"accession":"0001209191-15-005167","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-005167","line_url":"/filing/0001209191-15-005167#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":27.808,"price_display":"27.81","price_state":"stated","total_value":5561.6,"total_display":"5,561.60","total_whole":"5,562","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-20","filed_date":"2015-01-20","scope":"insider"},{"id":8058932,"accession":"0001209191-15-004727","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-004727","line_url":"/filing/0001209191-15-004727#line-5","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12601.0,"shares_display":"12,601","price_per_share":27.006,"price_display":"27.01","price_state":"stated","total_value":340302.606,"total_display":"340,302.61","total_whole":"340,303","shares_owned_after":875.0,"shares_owned_after_display":"875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-16","filed_date":"2015-01-16","scope":"insider"},{"id":8058922,"accession":"0001209191-15-004727","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-004727","line_url":"/filing/0001209191-15-004727#line-4","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":27.314,"price_display":"27.31","price_state":"stated","total_value":23899.75,"total_display":"23,899.75","total_whole":"23,900","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-16","filed_date":"2015-01-16","scope":"insider"},{"id":8058915,"accession":"0001209191-15-004727","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-004727","line_url":"/filing/0001209191-15-004727#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6524.0,"shares_display":"6,524","price_per_share":26.776,"price_display":"26.78","price_state":"stated","total_value":174686.624,"total_display":"174,686.62","total_whole":"174,687","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-15","filed_date":"2015-01-16","scope":"insider"},{"id":6272441,"accession":"0001209191-14-070444","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-14-070444","line_url":"/filing/0001209191-14-070444#line-7","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14800.0,"shares_display":"14,800","price_per_share":26.979,"price_display":"26.98","price_state":"stated","total_value":399289.2,"total_display":"399,289.20","total_whole":"399,289","shares_owned_after":200.0,"shares_owned_after_display":"200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-20","filed_date":"2014-11-20","scope":"insider"},{"id":6272438,"accession":"0001209191-14-070444","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-14-070444","line_url":"/filing/0001209191-14-070444#line-6","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":27.17,"price_display":"27.17","price_state":"stated","total_value":5434.0,"total_display":"5,434.00","total_whole":"5,434","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-20","filed_date":"2014-11-20","scope":"insider"},{"id":6272435,"accession":"0001209191-14-070444","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-070444","line_url":"/filing/0001209191-14-070444#line-4","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":26.684,"price_display":"26.68","price_state":"stated","total_value":400260.0,"total_display":"400,260.00","total_whole":"400,260","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-19","filed_date":"2014-11-20","scope":"insider"},{"id":6272432,"accession":"0001209191-14-070444","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-070444","line_url":"/filing/0001209191-14-070444#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":27.317,"price_display":"27.32","price_state":"stated","total_value":273170.0,"total_display":"273,170.00","total_whole":"273,170","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-20","scope":"insider"},{"id":6236723,"accession":"0001209191-14-069292","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-14-069292","line_url":"/filing/0001209191-14-069292#line-8","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":26.747,"price_display":"26.75","price_state":"stated","total_value":267470.0,"total_display":"267,470.00","total_whole":"267,470","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-17","filed_date":"2014-11-17","scope":"insider"},{"id":6236714,"accession":"0001209191-14-069292","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-069292","line_url":"/filing/0001209191-14-069292#line-5","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":26.559,"price_display":"26.56","price_state":"stated","total_value":265590.0,"total_display":"265,590.00","total_whole":"265,590","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-14","filed_date":"2014-11-17","scope":"insider"},{"id":6236708,"accession":"0001209191-14-069292","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-069292","line_url":"/filing/0001209191-14-069292#line-3","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":26.567,"price_display":"26.57","price_state":"stated","total_value":212536.0,"total_display":"212,536.00","total_whole":"212,536","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-13","filed_date":"2014-11-17","scope":"insider"},{"id":6236704,"accession":"0001209191-14-069292","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-069292","line_url":"/filing/0001209191-14-069292#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":27.524,"price_display":"27.52","price_state":"stated","total_value":55048.0,"total_display":"55,048.00","total_whole":"55,048","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-13","filed_date":"2014-11-17","scope":"insider"},{"id":6592694,"accession":"0001209191-14-046107","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-14-046107","line_url":"/filing/0001209191-14-046107#line-6","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.459,"price_display":"30.46","price_state":"stated","total_value":304590.0,"total_display":"304,590.00","total_whole":"304,590","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-03","filed_date":"2014-07-03","scope":"insider"},{"id":6592690,"accession":"0001209191-14-046107","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-046107","line_url":"/filing/0001209191-14-046107#line-4","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.743,"price_display":"30.74","price_state":"stated","total_value":307430.0,"total_display":"307,430.00","total_whole":"307,430","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-02","filed_date":"2014-07-03","scope":"insider"},{"id":6592685,"accession":"0001209191-14-046107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-046107","line_url":"/filing/0001209191-14-046107#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.032,"price_display":"30.03","price_state":"stated","total_value":300320.0,"total_display":"300,320.00","total_whole":"300,320","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-01","filed_date":"2014-07-03","scope":"insider"},{"id":6615354,"accession":"0001209191-14-044545","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-044545","line_url":"/filing/0001209191-14-044545#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":29.231,"price_display":"29.23","price_state":"stated","total_value":292310.0,"total_display":"292,310.00","total_whole":"292,310","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-30","filed_date":"2014-07-01","scope":"insider"},{"id":6647326,"accession":"0001209191-14-037210","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-14-037210","line_url":"/filing/0001209191-14-037210#line-8","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5098.0,"shares_display":"5,098","price_per_share":21.449,"price_display":"21.45","price_state":"stated","total_value":109347.002,"total_display":"109,347.00","total_whole":"109,347","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-27","filed_date":"2014-05-27","scope":"insider"},{"id":6647323,"accession":"0001209191-14-037210","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-14-037210","line_url":"/filing/0001209191-14-037210#line-7","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4902.0,"shares_display":"4,902","price_per_share":20.974,"price_display":"20.97","price_state":"stated","total_value":102814.548,"total_display":"102,814.55","total_whole":"102,815","shares_owned_after":5098.0,"shares_owned_after_display":"5,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-27","filed_date":"2014-05-27","scope":"insider"},{"id":6647317,"accession":"0001209191-14-037210","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-037210","line_url":"/filing/0001209191-14-037210#line-5","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.603,"price_display":"20.60","price_state":"stated","total_value":206030.0,"total_display":"206,030.00","total_whole":"206,030","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-23","filed_date":"2014-05-27","scope":"insider"},{"id":6647312,"accession":"0001209191-14-037210","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-037210","line_url":"/filing/0001209191-14-037210#line-3","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5523.0,"shares_display":"5,523","price_per_share":20.388,"price_display":"20.39","price_state":"stated","total_value":112602.924,"total_display":"112,602.92","total_whole":"112,603","shares_owned_after":4477.0,"shares_owned_after_display":"4,477","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-22","filed_date":"2014-05-27","scope":"insider"},{"id":6647309,"accession":"0001209191-14-037210","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-037210","line_url":"/filing/0001209191-14-037210#line-2","is_derivative":false,"issuer_cik":"0001269021","issuer_name":"PORTOLA PHARMACEUTICALS INC","issuer_ticker":"PTLA","issuer_name_source":null,"issuer_url":"/issuer/0001269021","owner_cik":"0001574558","owner_name":"Lis William","owner_display_name":"Lis William","owner_url":"/insider/0001574558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4477.0,"shares_display":"4,477","price_per_share":21.011,"price_display":"21.01","price_state":"stated","total_value":94066.247,"total_display":"94,066.25","total_whole":"94,066","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-22","filed_date":"2014-05-27","scope":"insider"}],"next_cursor":"2014-05-22|6647309","ledger_fault":false,"count":{"value":51,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":51,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":51},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001704292","name":"Zai Lab Ltd","url":"/issuer/0001704292","role":"Director","n_filings":7,"first_seen":"2022-01-21","last_seen":"2026-08-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001788028","name":"Jasper Therapeutics, Inc.","url":"/issuer/0001788028","role":"Director","n_filings":3,"first_seen":"2022-06-28","last_seen":"2023-10-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001269021","name":"PORTOLA PHARMACEUTICALS INC","url":"/issuer/0001269021","role":"Director, Officer (Chief Executive Officer)","n_filings":17,"first_seen":"2014-05-21","last_seen":"2018-06-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001574558","retrieved_at":"2026-08-22T05:14:11+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}